Add to ORKGRecently published WHO guidance recommends starting ART in HIV-infected adults with CD4 counts of ≤350 cells/μl [1]. There is mounting evidence that such a policy will lead to lower mortality among HIV-infected individuals [2]. Also modeling data suggests that expanded testing and earlier treatment will reduce HIV transmission [3]. In South Africa ART coverage is not meeting current needs, even using the CD4 count criteria of <200 cells/μl, and mortality early in ART programmes is high due to advanced immunosuppression at initiation [4]. Fortunately, following limited government leadership around HIV in the past, South African President Jacob Zuma has encouraged widespread HIV testing, and announced that he will undertake an HIV test [5]
While momentum for increasing treatment thresholds is growing, if patients cannot be retained in HIV...
The hugely welcome government-led initiative to pro-actively offer ‘opt-out’ HIV testing to patients...
International audienceBackground: While WHO recommendations are to treat people earlier and earlier,...
BACKGROUND: Few studies have evaluated access to and retention in pre-ART care. Objectives To evalua...
Background: South Africa has undergone multiple expansions in antiretroviral therapy (ART) eligibili...
Despite a decade of advancing HIV/AIDS treatment policy in South Africa, 20% of people living with H...
BACKGROUND: Universal antiretroviral therapy (ART), as per the 2015 WHO recommendations, might reduc...
BACKGROUND: Antiretroviral therapy (ART) has been scaled-up rapidly in Africa. Programme reports typ...
Cryptococcal meningitis (CM) is a major cause of death among HIV-infected individuals. It causes an ...
BACKGROUND:Patients accessing antiretroviral treatment (ART) programmes in sub-Saharan Africa freque...
BACKGROUND: In sub-Saharan Africa, data for short-term risk of AIDS or death, which might inform dec...
International audienceBACKGROUND: Universal antiretroviral therapy (ART), as per the 2015 WHO recomm...
Access to antiretroviral therapy (ART) is expanding at a rapid rate in resource-limited settings, wi...
BACKGROUND: The World Health Organization recommends initiating antiretroviral therapy (ART) regardl...
To compare treatment outcomes by starting CD4 counts using data from the CIPRA-South Africa trial
While momentum for increasing treatment thresholds is growing, if patients cannot be retained in HIV...
The hugely welcome government-led initiative to pro-actively offer ‘opt-out’ HIV testing to patients...
International audienceBackground: While WHO recommendations are to treat people earlier and earlier,...
BACKGROUND: Few studies have evaluated access to and retention in pre-ART care. Objectives To evalua...
Background: South Africa has undergone multiple expansions in antiretroviral therapy (ART) eligibili...
Despite a decade of advancing HIV/AIDS treatment policy in South Africa, 20% of people living with H...
BACKGROUND: Universal antiretroviral therapy (ART), as per the 2015 WHO recommendations, might reduc...
BACKGROUND: Antiretroviral therapy (ART) has been scaled-up rapidly in Africa. Programme reports typ...
Cryptococcal meningitis (CM) is a major cause of death among HIV-infected individuals. It causes an ...
BACKGROUND:Patients accessing antiretroviral treatment (ART) programmes in sub-Saharan Africa freque...
BACKGROUND: In sub-Saharan Africa, data for short-term risk of AIDS or death, which might inform dec...
International audienceBACKGROUND: Universal antiretroviral therapy (ART), as per the 2015 WHO recomm...
Access to antiretroviral therapy (ART) is expanding at a rapid rate in resource-limited settings, wi...
BACKGROUND: The World Health Organization recommends initiating antiretroviral therapy (ART) regardl...
To compare treatment outcomes by starting CD4 counts using data from the CIPRA-South Africa trial
While momentum for increasing treatment thresholds is growing, if patients cannot be retained in HIV...
The hugely welcome government-led initiative to pro-actively offer ‘opt-out’ HIV testing to patients...
International audienceBackground: While WHO recommendations are to treat people earlier and earlier,...